STOCK TITAN

BlackRock holds 14.3% of Chemours (NYSE: CC) — 21.48M shares reported

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

BlackRock, Inc. amended a Schedule 13G/A to report beneficial ownership of 21,484,477 shares of Chemours Company common stock, representing 14.3% of the class. The filing shows sole voting power for 21,244,817 shares and sole dispositive power for 21,484,477 shares. The filing notes that iShares Core S&P Small-Cap ETF has an interest exceeding 5% in Chemours common stock. The amendment is signed by Spencer Fleming, Managing Director, dated 04/24/2026.

Positive

  • None.

Negative

  • None.

Insights

BlackRock reports a 14.3% stake in Chemours, with primary voting and dispositive control.

BlackRock's Schedule 13G/A amendment lists 21,484,477 shares beneficially owned and records 21,244,817 shares as sole voting power. This indicates consolidated reporting by BlackRock's Reporting Business Units under SEC guidance.

Large passive positions like this reflect institutional exposure rather than an active takeover intent; subsequent filings (e.g., ownership changes or Form 13D) would show any change in intent or activism. Future ownership updates will appear in amended schedules if BlackRock's holdings or voting arrangements change.

Beneficial ownership 21,484,477 shares Amount beneficially owned as stated in Item 4
Percent of class 14.3% Percent of common stock as stated in Item 4
Sole voting power 21,244,817 shares Sole power to vote as stated in Item 4(c)(i)
Sole dispositive power 21,484,477 shares Sole power to dispose as stated in Item 4(c)(iii)
Notable >5% holder noted iShares Core S&P Small-Cap ETF Listed in Item 6 as having interest >5%
Schedule 13G/A regulatory
"amended a Schedule 13G/A to report beneficial ownership"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially owned financial
"Amount beneficially owned: 21484477"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 21484477"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Reporting Business Units other
"beneficially owned by certain business units (collectively, the "Reporting Business Units")"





163851108

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



BlackRock, Inc.
Signature:Spencer Fleming
Name/Title:Managing Director
Date:04/24/2026
Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7

FAQ

What stake does BlackRock report in Chemours (CC)?

BlackRock reports beneficial ownership of 21,484,477 shares, representing 14.3% of Chemours common stock. The filing discloses both voting and dispositive powers held by BlackRock's Reporting Business Units.

Does BlackRock have voting control over the shares of CC?

The amendment shows sole voting power for 21,244,817 shares and sole dispositive power for 21,484,477 shares. These figures reflect the powers attributed to BlackRock's Reporting Business Units in the filing.

Is any other entity a large holder of Chemours mentioned in the filing?

Yes. The filing states that iShares Core S&P Small-Cap ETF has an interest exceeding 5% in Chemours common stock, identified under Item 6 as a holder on whose behalf BlackRock reports.

Who signed the Schedule 13G/A amendment for BlackRock?

The amendment is signed by Spencer Fleming, Managing Director, with the signature date shown as 04/24/2026, certifying the reported beneficial ownership figures.

What does a Schedule 13G/A filing indicate for CC shareholders?

A Schedule 13G/A reports passive beneficial ownership by an institutional investor; BlackRock's amendment quantifies its 21,484,477-share (14.3%) position. It does not by itself indicate an activist intent or change in strategy.